NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its Board of Directors has initiated a share repurchase program on Tuesday, October 31st 2017, which permits the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its stock is undervalued.

Trueblue Inc (NYSE:TBI) released its quarterly earnings results on Monday, April, 30th. The business services provider reported $0.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.22 by $0.09. The business services provider earned $554.39 million during the quarter, compared to analysts' expectations of $570.40 million. Trueblue had a return on equity of 13.81% and a net margin of 2.39%. The firm's quarterly revenue was down 2.4% on a year-over-year basis. During the same period last year, the business earned $0.21 earnings per share. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue issued an update on its second quarter earnings guidance on Monday, April, 30th. The company provided earnings per share (EPS) guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 brokerages have issued twelve-month price targets for Trueblue's stock. Their forecasts range from $26.00 to $29.00. On average, they expect Trueblue's share price to reach $27.50 in the next year. View Analyst Ratings for Trueblue.

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kelly Services, Inc. Class B (KELYB), Kforce (KFRC), Kelly Services, Inc. Class A (KELYA), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

Press coverage about TBI stock has been trending somewhat positive recently, according to Accern. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Trueblue earned a coverage optimism score of 0.22 on Accern's scale. They also assigned news articles about the business services provider an impact score of 47.45 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Trueblue's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.87%), Dimensional Fund Advisors LP (5.65%), JPMorgan Chase & Co. (3.98%), Hood River Capital Management LLC (1.51%), Prudential Financial Inc. (1.48%) and Northern Trust Corp (1.26%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including A.R.T. Advisors LLC, Thrivent Financial for Lutherans, California Public Employees Retirement System, Cubist Systematic Strategies LLC, Citigroup Inc., Rothschild Asset Management Inc., LaSalle Street Capital Management LLC and Guggenheim Capital LLC. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Matarin Capital Management LLC, Heartland Advisors Inc., Mackay Shields LLC, Dimensional Fund Advisors LP, Millennium Management LLC, Prudential Financial Inc., LSV Asset Management and Barclays PLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.80.

Trueblue has a market capitalization of $1.15 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]